GK
Glaukos
GKOS · NYSE
$177.48 -1.59% (-$2.87)
1M -2.18%
Market Cap $10.5B
P/E Ratio -
Div. Yield -
ROE 27.07%
Bulios Fair Price
$123.94
30.2% downside
Current Price
$177.48
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GKOS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 17.08x
P/B 15.34x
P/E N/A
Growth
92 /100
Growing Rev. growth 21.51%
Book val. growth 7.38%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 79.12%
Net margin 30.68%
Op. margin 13.13%
Quality
8 /100
Poor ROIC 9.59%
ROE 27.07%
ROA 20.43%
Debt
69 /100
Low Debt/Equity 0.15x
Current ratio 5.04x
Int. coverage -38.21x
Stability
81 /100
Stable Beta 0.76x
Rev. volatility 10.53%
EPS volatility 16.73%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GKOS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Thomas William Burns
Employees
1,094
Headquarters
Aliso Viejo
Upcoming events
04 NOV
Earnings
Upcoming earnings report